<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">73760</article-id><article-id pub-id-type="doi">10.7554/eLife.73760</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-254641"><name><surname>Chalabi Hajkarim</surname><given-names>Morteza</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2039-2676</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254642"><name><surname>Karjalainen</surname><given-names>Ella</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254643"><name><surname>Osipovitch</surname><given-names>Mikhail</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254644"><name><surname>Dimopoulos</surname><given-names>Konstantinos</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254645"><name><surname>Gordon</surname><given-names>Sandra L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0270-8291</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254646"><name><surname>Ambri</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254647"><name><surname>Rasmussen</surname><given-names>Kasper Dindler</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-254648"><name><surname>Grønbæk</surname><given-names>Kirsten</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-137079"><name><surname>Helin</surname><given-names>Kristian</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-131223"><name><surname>Wennerberg</surname><given-names>Krister</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1352-4220</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-254649"><name><surname>Won</surname><given-names>Kyoung-Jae</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Biotech Research and Innovation Centre (BRIC)</institution>, <institution>University of Copenhagen</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff2"><institution content-type="dept">Institute for Molecular Medicine Finland</institution>, <institution>University of Helsinki</institution>, <addr-line><named-content content-type="city">Helsinki</named-content></addr-line>, <country>Finland</country></aff><aff id="aff3"><institution>Rigshospitalet</institution>, <addr-line><named-content content-type="city">Copenhagen</named-content></addr-line>, <country>Denmark</country></aff><aff id="aff4"><institution content-type="dept">School of Life Sciences</institution>, <institution>University of Dundee</institution>, <addr-line><named-content content-type="city">Dundee</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Cell Biology Program</institution>, <institution>Memorial Sloan Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-50904"><name><surname>Walczak</surname><given-names>Aleksandra M</given-names></name><role>Reviewing editor</role><aff><institution>CNRS LPENS</institution>, <country>France</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>krister.wennerberg@bric.ku.dk</email> (KW);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>kyoung.won@bric.ku.dk</email> (KW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>02</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e73760</elocation-id><history><date date-type="received"><day>09</day><month>09</month><year>2021</year></date><date date-type="accepted"><day>14</day><month>02</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Chalabi Hajkarim et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Chalabi Hajkarim et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-73760-v1.pdf"/><abstract><p>Large-scale multiparameter screening has become increasingly feasible and straightforward to perform thanks to developments in technologies such as high-content microscopy and high-throughput flow cytometry. The automated toolkits for analyzing similarities and differences between large numbers of tested conditions have not kept pace with these technological developments. Thus, effective analysis of multiparameter screening datasets becomes a bottleneck and a limiting factor in unbiased interpretation of results. Here we introduce compaRe, a toolkit for large-scale multiparameter data analysis, which integrates quality control, data bias correction, and data visualization methods with a mass-aware gridding algorithm-based similarity analysis providing a much faster and more robust analyses than existing methods. Using mass and flow cytometry data from acute myeloid leukemia and myelodysplastic syndrome patients, we show that compaRe can reveal interpatient heterogeneity and recognizable phenotypic profiles. By applying compaRe to high-throughput flow cytometry drug response data in AML models, we robustly identified multiple types of both deep and subtle phenotypic response patterns, highlighting how this analysis could be used for therapeutic discoveries. In conclusion, compaRe is a toolkit that uniquely allows for automated, rapid, and precise comparisons of large-scale multiparameter datasets, including high-throughput screens.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Novo Nordisk Foundation center for Stem Cell Biology</institution></institution-wrap></funding-source><award-id>NNF17CC0027852</award-id><principal-award-recipient><name><surname>Grønbæk</surname><given-names>Kirsten</given-names></name><name><surname>Helin</surname><given-names>Kristian</given-names></name><name><surname>Wennerberg</surname><given-names>Krister</given-names></name><name><surname>Won</surname><given-names>Kyoung-Jae</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008363</institution-id><institution>Kræftens Bekæmpelse</institution></institution-wrap></funding-source><award-id>R223&amp;#x2010;A13071</award-id><principal-award-recipient><name><surname>Grønbæk</surname><given-names>Kirsten</given-names></name><name><surname>Helin</surname><given-names>Kristian</given-names></name><name><surname>Wennerberg</surname><given-names>Krister</given-names></name><name><surname>Won</surname><given-names>Kyoung-Jae</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The informed consent, and consent to publish of patient samples in this study has been approved by the Danish National Science Ethics Committee/National Videnskabsetisk Komite: Målrettet behandling af patienter med blodsygdomme, license no. 1705391.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Mass cytometry datasets were downloaded from Cytobank Community with the experiment ID 44185. AML mouse and human high-throughput flow cytometry data have been deposited in FLOWRepository with the repository IDs FR-FCM-Z357 and FR-FCM-Z3DP respectively. Flow cytometry data of AML and MDS patients have been deposited in FLOWRepository with the repository ID FR-FCM-Z3ET. Acquisition, installation and more technical details are available in compaRe's online tutorial on (https://github.com/morchalabi/COMPARE-suite). Similarity measurement and clustering modules as stand-alone tools have been merged into a separate R package and are available for download at (https://github.com/morchalabi/compaRe).</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Morteza C H</collab><collab>Ella K</collab><collab>Mikhail O</collab><collab>Konstantinos D</collab><collab>Sandra L G</collab><collab>Francesca A</collab><collab>Kasper D R</collab><collab>Kirsten G</collab><collab>Kristian H</collab><collab>Krister W</collab><collab>Kyoung-Jae W</collab></person-group><year iso-8601-date="2021">2021</year><source>AML/MDS Flow Cytometry</source><ext-link ext-link-type="uri" xlink:href="https://flowrepository.org/id/FR-FCM-Z3ET">https://flowrepository.org/id/FR-FCM-Z3ET</ext-link><comment>FR-FCM-Z3ET</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Morteza C H</collab><collab>Ella K</collab><collab>Mikhail O</collab><collab>Konstantinos D</collab><collab>Sandra L G</collab><collab>Francesca A</collab><collab>Kasper D R</collab><collab>Kirsten G</collab><collab>Kristian H</collab><collab>Krister W</collab><collab>Kyoung-Jae W</collab></person-group><year iso-8601-date="2021">2021</year><source>AML Mouse High-throughput Flow Cytometry</source><ext-link ext-link-type="uri" xlink:href="https://flowrepository.org/id/FR-FCM-Z357">https://flowrepository.org/id/FR-FCM-Z357</ext-link><comment>FR-FCM-Z357</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Morteza C H</collab><collab>Ella K</collab><collab>Mikhail O</collab><collab>Konstantinos D</collab><collab>Sandra L G</collab><collab>Francesca A</collab><collab>Kasper D R</collab><collab>Kirsten G</collab><collab>Kristian H</collab><collab>Krister W</collab><collab>Kyoung-Jae W</collab></person-group><year iso-8601-date="2021">2021</year><source>AML Human High-throughput Flow Cytometry</source><ext-link ext-link-type="uri" xlink:href="https://flowrepository.org/id/FR-FCM-Z3DP">https://flowrepository.org/id/FR-FCM-Z3DP</ext-link><comment>FR-FCM-Z3DP</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Morteza CH</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>Comprehensive and unbiased multiparameter high-throughput screening by compaRe finds effective and subtle drug responses in AML models</source><ext-link ext-link-type="uri" xlink:href="https://github.com/morchalabi/compaRe">https://github.com/morchalabi/compaRe</ext-link><comment>GitHub</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Levine JH</collab><collab>Simonds EF</collab><collab>Bendall SC</collab><collab>Davis KL</collab><collab>Amir el AD</collab><collab>Tadmor MD</collab><collab>et al</collab></person-group><year iso-8601-date="2015">2015</year><source>Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis</source><ext-link ext-link-type="uri" xlink:href="https://premium.cytobank.org/cytobank/experiments">https://premium.cytobank.org/cytobank/experiments</ext-link><comment>44185</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-73760-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>